A sensible approach to targeting STAT3-mediated transcription

Por Bhola, Neil E., Johnson, Daniel E., Grandis, Jennifer R.
Publicado no Ann Transl Med (2016)

Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors

Por Chakrabarty, Anindita, Bhola, Neil E., Sutton, Cammie, Ghosh, Ritwik, Kuba, María Gabriela, Dave, Bhuvanesh, Chang, Jenny C., Arteaga, Carlos L.
Publicado em 2012

Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab

Por Bhola, Neil E., Thomas, Sufi M., Freilino, Maria, Joyce, Sonali, Sahu, Anirban, Maxwell, Jessica, Argiris, Athanassios, Seethala, Raja, Grandis, Jennifer R.
Publicado em 2011

Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth

Por Hover, Laura D., Young, Christian D., Bhola, Neil E., Wilson, Andrew J., Khabele, Dineo, Hong, Charles C., Moses, Harold L., Owens, Philip
Publicado no Cancer Lett (2015)

Treatment of Triple Negative Breast Cancer With TORC1/2 Inhibitors Sustains a Drug-resistant and Notch-dependent Cancer Stem Cell Population

Por Bhola, Neil E., Jansen, Valerie M., Koch, James P., Li, Hua, Formisano, Luigi, Williams, Janice A., Grandis, Jennifer R., Arteaga, Carlos L.
Publicado no Cancer Res (2015)

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

Por Bhola, Neil E., Balko, Justin M., Dugger, Teresa C., Kuba, María Gabriela, Sánchez, Violeta, Sanders, Melinda, Stanford, Jamie, Cook, Rebecca S., Arteaga, Carlos L.
Publicado em 2013

Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer

Por Balko, Justin M., Schwarz, Luis J., Bhola, Neil E., Kurupi, Richard, Owens, Phillip, Miller, Todd W., Gómez, Henry, Cook, Rebecca S., Arteaga, Carlos L.
Publicado em 2013

Honokiol inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors

Por Leeman-Neill, Rebecca J., Cai, Quan, Joyce, Sonali C., Thomas, Sufi M., Bhola, Neil E., Neill, Daniel B., Arbiser, Jack L., Grandis, Jennifer R.
Publicado em 2010

Anti-tumor mechanisms of targeting the PDK1 pathway in head and neck cancer

Por Bhola, Neil E., Freilino, Maria L., Joyce, Sonali C., Sen, Malabika, Thomas, Sufi M., Sahu, Anirban, Cassell, Andre, Chen, Ching-Shih, Grandis, Jennifer R.
Publicado em 2012

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Por Balko, Justin M, Cook, Rebecca S, Vaught, David B, Kuba, María G, Miller, Todd W, Bhola, Neil E, Sanders, Melinda E, Granja-Ingram, Nara M, Smith, J Joshua, Meszoely, Ingrid M, Salter, Janine, Dowsett, Mitch, Stemke-Hale, Katherine, González-Angulo, Ana M, Mills, Gordon B, Pinto, Joseph A, Gómez, Henry L, Arteaga, Carlos L
Publicado em 2012

Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer

Por Young, Christian D., Zimmerman, Lisa J., Hoshino, Daisuke, Formisano, Luigi, Hanker, Ariella B., Gatza, Michael L., Morrison, Meghan M., Moore, Preston D., Whitwell, Corbin A., Dave, Bhuvanesh, Stricker, Thomas, Bhola, Neil E., Silva, Grace O., Patel, Premal, Brantley-Sieders, Dana M., Levin, Maren, Horiates, Marina, Palma, Norma A., Wang, Kai, Stephens, Philip J., Perou, Charles M., Weaver, Alissa M., O'Shaughnessy, Joyce A., Chang, Jenny C., Park, Ben Ho, Liebler, Daniel C., Cook, Rebecca S., Arteaga, Carlos L.
Publicado no Mol Cell Proteomics (2015)